Adriamycin Therapy
New adriamycin therapy research reported from Sichuan University
Published in Fitness and Wellness Business Week, March 17th, 2010
Fresh data on adriamycin therapy are presented in the report 'Synthesis, characterization, and in vitro and in vivo evaluation of a novel pectin-adriamycin conjugate.' According to a study from Chengdu, People's Republic of China, "Adriamycin (ADM) has been widely used in the treatment of many types of solid malignant tumor. However, cardiotoxicity, multidrug resistance and a short half-life in vivo are significant problems that limit its clinical application."
"To resolve these problems, a novel pectin-adriamycin conjugate (PAC) was synthesized by attaching ADM to low-methoxylated pectin via an amide linkage. The ADM content and weight-average molecular weight (Mw) of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Fitness and Wellness Business Week
More Articles from Fitness and Wellness Business Week
- 3DISC
3DISC Introduces Affordable CR Solution for Clinics of Any Size - Adipose Tissue
New adipose tissue study findings have been reported by scientists at Pohang University of Science and Technology - Age and Aging
Data on age and aging published by Y. Onem and colleagues - Alcoholism
New alcoholism study findings have been reported from Gorlaeus Laboratories - Allviant
Allviant Appoints Worksite Wellness and Health Promotion Expert Steve Giardini to Advisory Board - Altarum Institute
New Analysis Calls for State and Federal Action to Track Childhood Obesity - More from this issue of Fitness and Wellness Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
